Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic ... (reatment in Patients with Partial-Onset ...)

Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R)

Date:6/28/2009

reatment in Patients with Partial-Onset Seizures: Pooled Analysis of Three Double-Blind Phase III Clinical Studies. Poster presented at the American Epilepsy Society (AES) Congress, 5-9 December 2008, Seattle, WA, USA (Epilepsia, 49(Suppl. 7), 1-498, 2008).

6. WHO Atlas: Epilepsy Care in the World. WHO 2005

7. Mei PA, Montenegro MA, Guerreiro MM, Guerreiro CA. Pharmacovigilance in epileptic patients using antiepileptic drugs. Arq Neuropsiquiatr 2006 Jun;64(2A): 198-201. Epub 2006 Jun 9

8. Cramer J, Elger C, HalÃ¡sz P et al. An Evaluation of Quality of Life and Depressive Symptoms During Long-Term Treatment with Eslicarbazepine Acetate: BIA-2093-301 Study.QOL 301. Poster presented at the American Epilepsy Society (AES) Congress, 5-9 December 2009, Seattle, WA, USA (Epilepsia, 49(Suppl. 7), 1-498, 2008).

    For further information please contact
    Media contacts
    For more information please contact:
    BIAL (head office)
    Francisco OsÃ³rio
    Tel.: +351-22-986-6100
    Mobile: +351-96-346-9968
    francisco.osorio@bial.com

    Pat Pearson
    Red Health
    Tel.: +44-207-025-6572
    Mobile: +44-7734406688
    par.pearson@redconsultancy.com

SOURCE BIAL
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7
Related medicine technology :

1. Study Demonstrates Efficacy of Pitavastatin in Elderly Patients
2. Semafores SF1126, a Vascular Targeted Pan-PI3K/mTOR Inhibitor, Is Well Tolerated and Demonstrates Activity in Phase I Solid Tumor Patients
3. Ongoing Landmark ROADMAP Study Demonstrates Significant Improvement in Blood Pressure Control at One Year, According to Blinded Results
4. Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen
5. ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients
6. Study Demonstrates Restylane(R) Effect Lasted 18 Months in 97% of Patients With One Repeat Injection
7. ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients
8. Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells
9. Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia
10. Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL)
11. Thoratec Says Interim Data Analysis Demonstrates Statistical Superiority for the HeartMate II(R) in Destination Therapy Trial

Post Your Comments:

(Date:12/15/2009)... PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI ... 15, 2009 special dividend payment of $1.67 per share ... December 1, 2009. With this payment, distributions to ... $2.67 per share. In January 2010, the Company ... of the Company,s 2009 cash distributions and the allocation ...

(Date:12/15/2009)... BALTIMORE, Dec. 15 Champions Biotechnology, ... engaged in the development of advanced preclinical platforms ... of oncology drugs, today announced its financial results ... 2009. Full details of Company,s financial results ... www.championsbiotechnology.com . ,, Total revenues for the ...

(Date:12/15/2009)... KV Pharmaceutical Company ( KVa/KVb) today announced that ... notice (the "Notice") executed by the Marc S. Hermelin ... requesting that the Board of Directors of the Company ... by written consent relating to the proposed appointment of ... from Ronald J. Kanterman,s departure (the "Director Appointment"). ,, ...

Breaking Medicine Technology:PDL BioPharma Completes December 15 Special Dividend Payment 2 Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results 2 Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results 3 Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results 4 Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results 5 KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 2 KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 3 KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 4 KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 5 KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 6 KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 7 Proprietary EDM Machining Technology Boosts Speed and Accuracy for Medical Components 61534 1 Proprietary EDM Machining Technology Boosts Speed and Accuracy for Medical Components 61534 2 ASAP Systems Releases Latest Version of their Passport Inventory and Asset Tracking Software with New Security Features and Administrative Tools 61529 1 ASAP Systems Releases Latest Version of their Passport Inventory and Asset Tracking Software with New Security Features and Administrative Tools 61529 2 Smoking Causes Blindness 61525 1 Smoking Causes Blindness 61525 2

[0] PDL BioPharma Completes December 15 Special Dividend Payment [0] Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results [0] KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent

... March 12 Alimera Sciences, Inc., a privately ... development and commercialization of prescription ophthalmic pharmaceuticals, today ... from the first human pharmacokinetic study (PK Study) ... being developed for the treatment of diabetic macular ...

... 11 Royal DSM N.V., the global Life Sciences ... , today announces that DSM Biomedical obtained an exclusive ... developed by MediVas LLC, a San Diego ... platform, this will open up a broad range of opportunities ...

Other Medicine Technology:Alimera Reports Favorable Safety and Efficacy Results From the 12-Month Interim Readout of the Human PK Iluvien(TM) Study 2 Alimera Reports Favorable Safety and Efficacy Results From the 12-Month Interim Readout of the Human PK Iluvien(TM) Study 3 DSM Obtains Exclusive World-Wide License for Innovative Drug Delivery Technology 2 DSM Obtains Exclusive World-Wide License for Innovative Drug Delivery Technology 3 DSM Obtains Exclusive World-Wide License for Innovative Drug Delivery Technology 4

Alimera Reports Favorable Safety and Efficacy Results From the 12-Month Interim Readout of the Human PK Iluvien(TM) Study DSM Obtains Exclusive World-Wide License for Innovative Drug Delivery Technology

(Date:12/15/2009)... where all couples of reproductive age were evaluated, Italian ... The number of children born with cystic fibrosis decreases ... mutation carriers increases, a new study finds. , CF ... northeast Italy for many years. Since the 1990s, the ... number of infants born with CF. , Two different ...

(Date:12/15/2009)... some sobering statistics concerning the parallel rise in diabetes and obesity ... means of combating this trend afflicting their workforce. , ... ... are climbing across America due in large part to the alarming ... Association has stated that the rate of diabetes could be cut ...

(Date:12/15/2009)... BERWYN, Pa., Dec. 15 4R Systems, ... supply chain solutions which help retailers significantly increase ... chain decisions, announced today that The Vitamin Shoppe ... 2008. ,, "4R,s store and DC inventory solutions ... inventory efficiency and in-stocks over the last two ...

(Date:12/15/2009)... CITY, Dec. 15 The new compact LifeSpan ... ( www.LifeSpanFitness.com ), was highly praised by ... treadmills for 2010. The compact TR200 folding treadmill received ... Best Treadmill under $1000. ,, The compact LifeSpan ... in small workout spaces. "This category buster is a ...

(Date:12/15/2009)... A new study links chronic obstructive pulmonary disease, or ... sentinels to activate the body,s immune system. , ... to growing awareness of the immune system,s role in ... than 12 million Americans with wheezing, shortness of breath, ... key if doctors are to find better ways to ...

Breaking Medicine News(10 mins):Health News:Wider Adult Screening May Mean Fewer Children With Cystic Fibrosis 2 Health News:TrekDesk: A Potentially Positive Impact on Diabetes & Obesity 2 Health News:TrekDesk: A Potentially Positive Impact on Diabetes & Obesity 3 Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 2 Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 3 Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 4 Health News:Treadmill Reviews Rate Compact LifeSpan Treadmill Best Treadmill 2 Health News:Immune cell activity linked to worsening COPD 2 Health News:Immune cell activity linked to worsening COPD 3

[0] Wider Adult Screening May Mean Fewer Children With Cystic Fibrosis [2] TrekDesk: A Potentially Positive Impact on Diabetes & Obesity [1] 4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance [0] Treadmill Reviews Rate Compact LifeSpan Treadmill Best Treadmill [1] Immune cell activity linked to worsening COPD

... This release is available in German . ... very impressive, said the President of the Deutsche Forschungsgemeinschaft ... his feelings following the first reading of the amendment ... He emphasised that he was very pleased about how ...

... Fighting fat bloom can mean a prettier look for Valentines ... , Chemists in England and the Netherlands have discovered a ... and other goodies, looking fresher and tastier. Their finding, which ... chocolate, is scheduled for the March 12 issue of the ...

... Challenges Americans to Get Fit and Live a Healthier ... Lifestyle in 2008, ... is launching a multi-faceted campaign aimed at,helping women renew their commitment to a ... get when they,are able to fit into an old pair of skinny jeans., ...

... NY - Many studies on cocaine addiction - and ... dopamine transporters, proteins that reabsorb the brain,s "reward" chemical ... transporters from doing their recycling job, it leaves the ... Now a new study conducted at the U.S. Department ...

... and DC-3 Color Doppler Diagnostic Ultrasound Systems ... /Xinhua-PRNewswire-FirstCall/ -- Mindray,Medical International Limited (NYSE: ... of medical devices in China with a ... Jie Liu, Mindray,s,executive vice president of international ...

... Institute announced today that it has received a $1 million ... ways to prevent global prematurity and stillbirth. Prematurity claims the ... It is the leading cause of infant mortality in ... Over 3 million babies are stillborn each year worldwide, and ...

Politics has taken notice of science American Chemical Society's Weekly PressPac -- Feb. 13, 2008 Old London Launches Skinny Jeans Contest Cocaine's effects on brain metabolism may contribute to abuse Mindray to Exhibit at 2008 European Congress of Radiology Annual Meeting Researchers aim to prevent global prematurity and stillbirths

... The Self-Cath Closed System is ... a method for safe, simple catheterization ... urinary tract infections. It includes ... The new EasyOff tear tab ...

... The Self-Cath family of ... patients a variety of ... Each catheter is ... grade PVC and has ...

... The Self-Cath family ... offers patients a variety ... self-catheterization. Each catheter ... medical grade PVC and ...

... The Self-Cath family of ... patients a variety of ... Each catheter is ... grade PVC and has ...

Medicine Products:

Self-Cath Closed System Straight Tip, kit Self-Cath® Olive Tip Coude with Guide Stripe®Self-Cath® Pediatric Self-Cath® Straight Tip

Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic ...(reatment in Patients with Partial-Onset ...),Health